Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MCI-186 in ALS (Severity Classification III)
NCT00415519Phase 3Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of edaravone in amyotrophic lateral sclerosis (ALS), sponsored by Shionogi & Co., Ltd.. Started Dec 2006; status: completed.
02
Drugs
edaravone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00415519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00415519.